SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001125282-06-003150
Filing Date
2006-06-01
Accepted
2006-06-01 14:11:27
Documents
2
Period of Report
2006-05-30

Document Format Files

Seq Description Document Type Size
1 form.html 3  
1 form.xml 3 3439
2 k0325231.htm EX-24 4313
  Complete submission text file 0001125282-06-003150.txt   9588
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Issuer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address WIRES JOLLEY LLP 90 ADELAIDE STREET WEST, SUITE 200 TORONTO A6 M5H3V9
Business Address 416-366-4006
Wires David E (Reporting) CIK: 0001363878 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-25169 | Film No.: 06879576